Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology 7. Project Summary / Abstract The goal of the Washington University (WU) Paul Calabresi K12 Career Development Award for Clinical Oncology is to provide didactic coursework, mentored research practicums and specialized career development programs for senior fellows and junior faculty interested in academic careers in oncology. We propose the renewal of this K12 to continue training clinicians from diverse disciplines, including medical oncology, surgical oncology, gynecological oncology, radiation oncology and pediatric oncology, and basic research scientists to design and administer hypothesis-driven pilot/Phase I, Phase II, and Phase III cancer therapeutic clinical trials. We are requesting six slots per year to support senior fellows and junior faculty for two to three year appointments. To enhance our highly successful K12 program, we propose the following:
Aim 1 : Expand the workforce trained to design and execute rigorous oncologic clinical research. We propose to continue to fund six K12 Scholar positions per year at WU over the next five years to support clinician-scientists and non-clinician postdoctoral researchers from diverse disciplines focused on patient oriented cancer research.
Aim 2 : Optimize existing curricula, career development, short-term training, and mentored, hands-on research experiences pertinent to clinical trials and patient oriented research. We will expand upon our current opportunities to offer training in four tracks: Cancer Genomics, Translational Medicine, Patient Centered Outcomes Research, and Cancer Immunology and Cellular Therapy.
Aim 3 : Continue to develop and enhance robust evaluation and tracking of K12 scholars, faculty, mentors, curriculum, and training opportunities. We will monitor progress, demonstrate outcomes, and use short- and long-term results to improve clinical oncology research training. Successful completion of these aims will result in increased numbers of diverse, well-trained investigators who lead hypothesis driven cancer therapeutic clinical trials. By partnering with stakeholders early and throughout the translational enterprise, they will disseminate and implement their research findings in real world practice to advance rapid human health and health care improvements.
Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology 8. Project Narrative Rapid progress in cancer research has led to a number of novel breakthrough therapies recently. Physicians and scientists engaged in patient oriented cancer research need to be trained in emerging and rapidly changing areas of cancer research. We are able to detect changes in the genes inside a cell more accurately now than ever before. Newer drugs that effectively block the function of certain genes can be quite effective in some patients with cancer. Significant advances in immunotherapy offer new hope for patients with a wide variety of cancers. Along with these exciting advances, however, the costs of cancer care are increasing at an alarming rate. To address all these changes, the Washington University Paul Calabresi Oncology K12 Program aims to train a new generation of basic and clinical investigators in the areas of genetics/genomics, translational medicine, patient centered outcomes research, and cancer immunology and cellular therapy in order to advance healthcare delivery and outcomes for cancer patients.
| Wildes, Tanya M; Maggiore, Ronald J; Tew, William P et al. (2018) Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group. Support Care Cancer 26:3563-3570 |
| Waqar, Saiama N; Boehmer, Leigh; Morgensztern, Daniel et al. (2018) Immunogenicity of Influenza Vaccination in Patients With Cancer. Am J Clin Oncol 41:248-253 |
| Warner, Wayne A; Spencer, David H; Trissal, Maria et al. (2018) Expression profiling of snoRNAs in normal hematopoiesis and AML. Blood Adv 2:151-163 |
| Waqar, Saiama N; Samson, Pamela P; Robinson, Cliff G et al. (2018) Non-small-cell Lung Cancer With Brain Metastasis at Presentation. Clin Lung Cancer 19:e373-e379 |
| Fakhri, Bita; Fiala, Mark A; Tuchman, Sascha A et al. (2018) Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies. Clin Lymphoma Myeloma Leuk 18:219-224 |
| Cherian, Mathew A; Olson, Sydney; Sundaramoorthi, Hemalatha et al. (2018) An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia. J Biol Chem 293:6844-6858 |
| Wildes, Tanya M; Fiala, Mark A (2018) Falls in older adults with multiple myeloma. Eur J Haematol 100:273-278 |
| Waqar, Saiama N; Waqar, Sadaf H; Trinkaus, Kathryn et al. (2018) Brain Metastases at Presentation in Patients With Non-Small Cell Lung Cancer. Am J Clin Oncol 41:36-40 |
| Mian, Hira S; Wildes, Tanya M; Fiala, Mark A (2018) Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma. JCO Clin Cancer Inform 2018: |
| Christopher, Matthew J; Petti, Allegra A; Rettig, Michael P et al. (2018) Immune Escape of Relapsed AML Cells after Allogeneic Transplantation. N Engl J Med 379:2330-2341 |
Showing the most recent 10 out of 92 publications
